2023-03-01 2024-02-29 false No description of principal activity Capium Accounts Production 1.1 07462377 bus:FullAccounts 2023-03-01 2024-02-29 07462377 bus:Micro-entities 2023-03-01 2024-02-29 07462377 bus:AuditExempt-NoAccountantsReport 2023-03-01 2024-02-29 07462377 bus:SmallCompaniesRegimeForAccounts 2023-03-01 2024-02-29 07462377 bus:PrivateLimitedCompanyLtd 2023-03-01 2024-02-29 07462377 2023-03-01 2024-02-29 07462377 2024-02-29 07462377 bus:RegisteredOffice 2023-03-01 2024-02-29 07462377 core:WithinOneYear 2024-02-29 07462377 core:AfterOneYear 2024-02-29 07462377 bus:Director1 2023-03-01 2024-02-29 07462377 bus:Director1 2024-02-29 07462377 bus:Director1 2022-03-01 2023-02-28 07462377 bus:Director2 2023-03-01 2024-02-29 07462377 bus:Director2 2024-02-29 07462377 bus:Director2 2022-03-01 2023-02-28 07462377 2022-03-01 07462377 bus:LeadAgentIfApplicable 2023-03-01 2024-02-29 07462377 2022-03-01 2023-02-28 07462377 2023-02-28 07462377 core:WithinOneYear 2023-02-28 07462377 core:AfterOneYear 2023-02-28 07462377 bus:EntityAccountantsOrAuditors 2022-03-01 2023-02-28 07462377 bus:OrdinaryShareClass1 2023-03-01 2024-02-29 07462377 bus:OrdinaryShareClass1 2024-02-29 07462377 bus:OrdinaryShareClass1 2022-03-01 2023-02-28 07462377 bus:OrdinaryShareClass1 2023-02-28 07462377 core:ComputerEquipment 2023-03-01 2024-02-29 07462377 core:ComputerEquipment 2024-02-29 07462377 core:ComputerEquipment 2023-02-28 07462377 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2024-02-29 07462377 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2023-02-28 07462377 core:CostValuation core:Non-currentFinancialInstruments 2024-02-29 07462377 core:CostValuation core:Non-currentFinancialInstruments 2023-02-28 07462377 core:AdditionsToInvestments core:Non-currentFinancialInstruments 2024-02-29 07462377 core:DisposalsDecreaseInInvestments core:Non-currentFinancialInstruments 2024-02-29 07462377 core:RevaluationsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2024-02-29 07462377 core:Non-currentFinancialInstruments 2024-02-29 07462377 core:Non-currentFinancialInstruments 2023-02-28 iso4217:GBP xbrli:shares xbrli:pure
Registered Number: 07462377
England and Wales

 

 

 

ACCORD CLINICAL SUPPORT LIMITED


Unaudited Financial Statements
 


Period of accounts

Start date: 01 March 2023

End date: 29 February 2024
Directors AnnirudhaKumar Vora
KInjal Vora
Registered Number 07462377
Registered Office 16 BRIDGEWATER GARDENS
EDGWARE
Edgware
Middlesex
HA8 6AW
1
  2024   2023
    £ £   £ £
Fixed assets   1,514      2,018 
Current assets 491,260      493,359   
Creditors: amount falling due within one year (10,427)     (5,293)  
Net current assets   480,833      488,066 
Total assets less current liabilities   482,347      490,084 
Creditors: amount falling due after more than one year   (31,963)     (50,988)
Net assets   450,384      439,096 
 

         
Capital and reserves   450,384      439,096 
 
NOTES TO THE ACCOUNTS

General Information
ACCORD CLINICAL SUPPORT LIMITED is a private company, limited by shares, registered in England and Wales, registration number 07462377, registration address 16 BRIDGEWATER GARDENS, EDGWARE, Edgware, Middlesex, HA8 6AW. The trading address of the company is 61 HInkler Road, Harrow, Middlesex, HA3 9AT.

The presentation currency is £ sterling.
1.

Accounting policies

Significant accounting policies
Statement of compliance
These financial statements have been prepared in compliance with FRS 105 – The Financial Reporting Standard applicable in the UK and Republic of Ireland and the Companies Act 2006.
Basis of preparation
The financial statements have been prepared under the historical cost convention as modified by the revaluation of land and buildings and certain financial instruments measured at fair value in accordance with the accounting policies.
The financial statements are prepared in sterling which is the functional currency of the company.
2.

Average number of employees

Average number of employees during the year was 3 (2023 : 2).


For the year ended 29 February 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' Responsibilities:
The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.

These accounts have been prepared in accordance with the micro-entity provisions and FRS 105, the Financial Reporting Standard applicable to the micro-entities regime. The accounts have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. The income statement has not been delivered to the Registrar of Companies.
The financial statements were approved by the board of directors on 30 November 2024 and were signed on its behalf by:


--------------------------------
AnnirudhaKumar Vora
Director
2